Processa Pharmaceuticals (PCSA) Tax Rate (2012 - 2021)
Processa Pharmaceuticals' (PCSA) quarterly Tax Rate came in at 5.4% in Q4 2021, down 144.0% on a YoY basis from 12.27% in Q4 2020, and up 37.15% quarter-over-quarter from 3.94% in Q3 2021.
Analysis
Processa Pharmaceuticals (PCSA) Tax Rate (2012 - 2021) Analysis & Trends
Processa Pharmaceuticals (PCSA) has reported Tax Rate for 8 consecutive years, with 5.4% the latest figure, recorded in Q4 2021.
- For the quarter ending Q4 2021, Tax Rate fell 144.0% year-over-year to 5.4%; the trailing twelve-month figure through Dec 2021 stood at 4.44% (down 206.0% YoY), and the FY2025 full-year result was 21.0%, changed 0.0% from the prior year.
- Tax Rate rose to 5.4% in Q4 2021 per PCSA's latest filing, from 3.94% in the prior quarter.
- Across five years, Tax Rate topped out at 20.43% in Q1 2018 and bottomed at 41.1% in Q4 2017.
- Historically, Tax Rate has averaged 8.17% across 5 years, with a median of 11.74% in 2020.
- The sharpest annual moves came in 2018 and 2020: Tax Rate jumped 5885 bps in 2018, then tumbled 1182 bps in 2020.
- Over 5 years, Tax Rate stood at 41.1% in 2017, then soared by 143 bps to 17.75% in 2018, then declined by 3 bps to 17.17% in 2019, then plunged by 60 bps to 6.84% in 2020, then decreased by 21 bps to 5.4% in 2021.
- According to Business Quant data, Tax Rate over the past three periods registered 5.4%, 3.94%, and 4.16% for Q4 2021, Q3 2021, and Q2 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 10.65% |
| 10 | Processa Pharmaceuticals | 5.75 Mn | 5.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 5.40% |
| Sep 30, 2021 | 3.94% |
| Jun 30, 2021 | 4.16% |
| Mar 31, 2021 | 4.08% |
| Dec 31, 2020 | 6.84% |
| Sep 30, 2020 | 2.24% |
| Jun 30, 2020 | 10.70% |
| Mar 31, 2020 | 12.78% |
| Dec 31, 2019 | 17.17% |
| Sep 30, 2019 | 14.06% |
| Jun 30, 2019 | 14.97% |
| Mar 31, 2019 | 14.79% |
| Dec 31, 2018 | 17.75% |
| Sep 30, 2018 | 19.91% |
| Jun 30, 2018 | 18.72% |
| Mar 31, 2018 | 20.43% |
| Dec 31, 2017 | -41.10% |
| Sep 30, 2017 | 0.27% |
| Dec 31, 2015 | 0.01% |
| Sep 30, 2015 | 0.01% |